Inventia Life Science is a fast-growing biotechnology startup based in Sydney, Australia, that is revolutionising cancer research, drug discovery and regenerative medicine. Inventia’s digital drop-on-demand 3D bioprinting technology is a game changer for the rapid fabrication of living biological structures. The company’s RASTRUM 3D cell culture platform, winner of the 2019 Good Design Award of the Year and 2020 Fast Company World Changing Ideas Award, has already been adopted in leading medical research institutes creating printed 3D tissues that model real biology. Inventia Life Science is also working with its customers and collaborators on new high-throughput personalised screening approaches as well as with clinical partners to advance regenerative medicine in areas such as bioprinted skin for the repair of burns and wounds.
TRUMPF was founded in 1923 as a series of mechanical workshops and has since developed into one of the world’s leading companies for machine tools, laser technology, and electronics for industrial applications. Our mission is to further develop and digitally connect production technology, to make it even more efficient, precise, and future-proof.
We offer laser sources and flexible laser systems and technology support for micro processing, laser marking, laser cutting and welding, as well as additive manufacturing.
As the most recent strategic segment within Rousselot, we have drawn upon Rousselot’s 125+ years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop X-Pure®, an innovative range of purified gelatins and collagens specifically designed for (bio)medical applications. Offering unique advantages to assure performance, quality and safety, X-Pure is backed by strong scientific data and on-going research. Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help “Advancing medical science”.
Session Sponsor – Plenary
IOP Publishing is a society-owned scientific publisher, providing impact, recognition and value for the scientific community.
Wholly owned by the UK Institute of Physics, we work closely with researchers, academics, and partners worldwide to produce academic journals, ebooks, conference series, and digital products, covering the latest and best research in the physical sciences and beyond.
Session Sponsor – Industry
Established under NCRIS, the Australian National Fabrication Facility (ANFF) provides businesses and academics with open access to more than 500 state-of-the-art micro/nanofabrication facilities spread across 21 Australian locations.
For more than a decade, ANFF has been enabling research through a mixture of training, expert support and direct access.
From proving principles to producing prototypes and beyond, the ANFF network is helping to bring about new generations of:
- bioinks, 3D printers, and materials,
- medical devices,
- and more.
Session Sponsor – Biomaterials/Bioinks/Biopolymers
CollPlant is a regenerative medicine company developing technologies and products for tissue regeneration and organ manufacturing.
CollPlant developed a technology for mass production of rhCollagen in genetically-engineered tobacco plants, which is identical to the collagen produced by the human body.
CollPlant’s product pipeline includes 3D bioprinted implants for breast reconstruction and augmentation, 3D bioprinted surgical mesh for use in breast reconstruction procedures (in collaboration with 3D Systems), and a portfolio of bioinks for various indications.
The University of Wollongong (UOW) is a young and vibrant university with undiminished ambitions and a strong sense of who we are. To confront the challenges of a rapidly changing world we’ve made it our mission to help improve society, through research, innovation and collaboration. From next-gen materials engineering in medicine to tackling superbugs at a molecular level, our research is purposeful and positive.
UOW Researchers are internationally recognised as leaders in electromaterials research, and have made ground-breaking discoveries in Biofabrication. UOW is proud to be positioned as a global leader in research, training and translation in biofabrication. Together with our partners we’re working tirelessly to deliver 3D bioprinting solutions for real world clinical problems.